Clinical Trial Update: Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension [Phase 4]

View source ↗

Summary

Phase 4 study assessing the efficacy and safety of adding Omacor (omega-3-acid ethyl esters) to fenofibrate in hypertriglyceridemic patients, with an 8-week ext…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Antara (fenofibrate)
• Omacor (omega-3-acid ethyl esters)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertriglyceridemia | Phase 4 | Status: COMPLETED